News & Updates
Filter by Specialty:
Continued anti-VEGF use after disease control does not prevent nAMD recurrence
In patients with neovascular age-related macular degeneration (nAMD) who achieve functional and morphological disease stability, continuing treatment with antivascular endothelial growth factors (anti-VEGF) does not substantially reduce the risk of recurrence, reports a recent study.
Continued anti-VEGF use after disease control does not prevent nAMD recurrence
06 Apr 2022
Insulin pump, CGM use linked to better glucose control during pregnancy
The use of either an insulin pump or a continuous glucose monitoring (CGM) device among pregnant women with type 1 diabetes leads to improved glycaemic control, although pump use appears to be linked to higher birth weight measures, a study has found.
Insulin pump, CGM use linked to better glucose control during pregnancy
06 Apr 2022
High-intensity statins help lower cholesterol among diabetics
Treatment with rosuvastatin, given at moderate and high intensity doses, as well as simvastatin and atorvastatin, given at high intensity doses, modestly reduce levels of nonhigh-density lipoprotein cholesterol (non-HDL-C) in diabetic patients over 12 weeks compared with placebo, a study has shown.
High-intensity statins help lower cholesterol among diabetics
05 Apr 2022
Tech-enabled, team-based approach lowers HbA1c levels in youth with T1D
In children with type 1 diabetes (T1D), glycated haemoglobin A1c (HbA1c) significantly decreases at 12 months after diagnosis with the help of a technology-enabled, team-based approach to intensified new-onset education involving target setting, continuous glucose monitoring (CGM), and remote data review, results of a study have shown.